The World Trade Organization's intellectual property rules are preventing China from manufacturing its own generic HIV drugs, ultimately hurting Chinese AIDS patients, Doctors Without Borders said today. A recent WTO measure now under negotiation would make permanent a waiver that allows poor nations to import such drugs, but that would not help in China, said DWB. "There is a glaring lack of evidence that the measures proposed by the WTO would actually resolve the difficulties we are facing. Not even one patient has benefited from its use," said Ellen 't Hoen, DWB's director of access to essential medicines. "It seems that the WTO has decided to sacrifice access to medicines before the Hong Kong meeting, settling for inadequate measures simply to get it off the agenda." WTO members have until Dec. 1, 2007, to ratify the amendment.

Back to other news for December 12, 2005

Search the Newsroom archive